Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Sarah Joanne Williams

Principal Accounting Officer at AN2 Therapeutics, Inc. (ANTX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3K

Reported trades

Filed Stock Type Shares Price Value Since
Sep 4SEC ANTXAN2 Therapeutics, Inc. Sell 27266,311 held (−0%) $5.53 $2K -38.9%
Jun 2SEC ANTXAN2 Therapeutics, Inc. Sell 26566,583 held (−0%) $4.43 $1K -23.7%
Mar 5SEC ANTXAN2 Therapeutics, Inc. Sell 32766,848 held (−0%) $1.06 $347 +218.9%